While gaining advantage in the first quarter of 2020 amid the coronavirus outbreak, Vietnamese drug giants are predicted to face challenges in the upcoming months due to faults in the global ingredient supply chain.

Although strong solutions exist, the biggest Vietnamese drugmakers reported poor performance in the first three quarters of 2019, putting their future targets at risk. 

 The world needs greater transparency on the pricing of medicines, and an overhaul of some approaches, in order to increase access to life-saving drugs, 

France's Innate Pharma believes that its cash position and portfolio are sufficiently robust for the cancer drug company to remain independent for the time being and will seek co-development deals modeled on an agreement struck

 The race to find protection against the Zika virus is fueled by something often missing from tropical disease research: the potential for big profit.

 Pfizer Inc, beating out numerous other bidders, said it agreed to buy U.S. cancer drug company Medivation Inc for $14 billion in cash, adding its blockbuster prostate cancer drug Xtandi to the company's growing oncology roster.

 Makers of inhalers to treat asthma and chronic lung disease are racing to develop a new generation of smart devices with sensors to monitor if patients are using their puffers properly.

U.S. health officials on Thursday reported the first case in the country of a patient with an infection resistant to all known antibiotics, and expressed grave concern that the superbug could pose serious danger for routine infections if it spreads. 

 U.S. lawmakers on Tuesday approved a bill to provide financial incentives to companies developing treatments for the Zika virus, and the White House said President Barack Obama was expected to sign the legislation